MDL Track
MDL 2846
S.D. Ohio
Bard/Davol polypropylene hernia mesh
23,695 pending
Medical Device · claims involving Bard and Davol polypropylene mesh failures, adhesion, migration, and revision surgery
Defendant
C.R. Bard, Inc.
MDL / Track
MDL 2846
S.D. Ohio
Judge
Judge Edmund A. Sargus, Jr.
Plaintiffs
24,000+ pending
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
C.R. Bard and subsidiary Davol face over 25,000 product liability lawsuits consolidated in MDL 2846 (In re: Davol, Inc./C.R. Bard, Inc. Polypropylene Hernia Mesh Products Liability Litigation) before Judge Edmund A. Sargus Jr. in the Southern District of Ohio. In October 2024, Bard announced a global settlement expected to resolve tens of thousands of claims; however, at least 30 new lawsuits were added to the MDL per an April 1, 2025 JPML docket report, with new filings subject to strict Lone Pine requirements under Case Management Order #52 (July 6, 2024) mandating case-specific expert reports on causation within 90 days.
Causation Theory
Plaintiffs allege Bard's polypropylene-based hernia mesh products—including Ventralight, Ventralex, PerFix Plug, and 3D Max—cause severe complications through defective material composition. Central to the theory is Bard's use of Pro-fax 6523 resin, which manufacturer LyondellBasell allegedly deemed unsuitable for permanent human implantation. The polypropylene mesh is claimed to degrade in vivo, triggering inflammatory responses, adhesions, organ perforation, mesh migration, and infections requiring revision surgery.
Case Management Orders
Litigation status
MDL 2846 is in post-settlement administration following Becton Dickinson's October 2024 global settlement framework. Judge Edmund A. Sargus, Jr. (S.D. Ohio) has shifted focus to clearing the docket through the Intensive Settlement Process overseen by Special Masters. The court entered CMO #52 in July 2024 imposing a limited stay on discovery and motions during settlement negotiations; CMO #53 implemented Lone Pine-style docket control requirements.
MDL Track
MDL 2846
S.D. Ohio
Bard/Davol polypropylene hernia mesh
23,695 pending
State Court Activity
Rhode Island consolidated litigation settled October 2024
MDL 2846 Leadership
Plaintiff Leadership
Co-Lead Counsel
Timothy M. O'Brien
Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A.
tobrien@levinlaw.com850-435-7000Liaison Counsel
Executive Committee Chair
Executive Committee Member
Defense Leadership
Liaison Counsel
Geographic exposure
Bard sells over 60% of hernia mesh devices in United States. Products include Ventralight ST, Ventralex, PerFix Plug, 3DMax, Composix E/X — all polypropylene-based. October 2024 global settlement covers tens of thousands of historical claims; new filings continue with strict post-settlement requirements. Estimated 25,000+ total cases in MDL 2846 plus 12,000+ Rhode Island state court actions.
Bard headquartered and manufactures devices in Rhode Island. Over 12,000 lawsuits filed in Rhode Island state court under Judge Alice Bridget Gibney. October 2024 confidential settlements reached. Trevino v. Bard: $4.8M verdict (2022) for Hawaii plaintiff who filed in Rhode Island due to corporate presence.
MDL 2846, In Re: Davol, Inc./C.R. Bard, Inc. Polypropylene Hernia Mesh Products Liability Litigation, assigned to Judge Edmund A. Sargus Jr. Over 25,000 federal cases centralized. CMO 52 imposed limited stay on cases filed on or before July 6, 2024. October 2024 global settlement announced with payouts over 5-6 years.
Plaintiff Paul Trevino received Ventralex mesh implant in Hawaii, suffered gastrointestinal injuries. Filed in Rhode Island state court due to Bard's corporate presence. $4.8 million compensatory damages award (2022).
Post-global settlement filing: Nathaniel Bowman filed March 2025, alleging 3DMax Mesh (2010) and PerFix Plug (2021) implants requiring additional surgical interventions. Added to MDL 2846 after October 2024 settlement deadline.
Post-global settlement filing: Alfred Hankins filed March 14, 2025, alleging sequential failure of two Ventralex hernia mesh products requiring multiple surgeries. Centralized in MDL 2846. At least 30 new lawsuits added to MDL per April 1, 2025 JPML docket report.
Key defendants
C.R. Bard, Inc.
Role: Manufacturer
Core defendant in MDL 2846. Global settlement announced October 2024; CMO #52 (July 6, 2024) imposed Lone Pine requirements and limited stay pending MSA implementation. New filings post-settlement face strict docket control and 14-day pharmacy/physician disclosure requirements.
Davol, Inc.
Role: Manufacturer
Bard subsidiary and co-defendant in MDL 2846. Jointly liable under settlement. Fourth bellwether (Bryan v. C.R. Bard, Inc., 2:18-cv-1440, S.D. Ohio Feb. 1, 2024) resulted in partial summary judgment grant; defense strategy emphasizes device-specific testing and learned intermediary doctrine.
| Defendant | Role | Intelligence Note |
|---|---|---|
| C.R. Bard, Inc. | Manufacturer | Core defendant in MDL 2846. Global settlement announced October 2024; CMO #52 (July 6, 2024) imposed Lone Pine requirements and limited stay pending MSA implementation. New filings post-settlement face strict docket control and 14-day pharmacy/physician disclosure requirements. |
| Davol, Inc. | Manufacturer | Bard subsidiary and co-defendant in MDL 2846. Jointly liable under settlement. Fourth bellwether (Bryan v. C.R. Bard, Inc., 2:18-cv-1440, S.D. Ohio Feb. 1, 2024) resulted in partial summary judgment grant; defense strategy emphasizes device-specific testing and learned intermediary doctrine. |
Timeline
MDL 2846 Centralized in S.D. Ohio
JPML transfers federal Bard hernia mesh cases to Southern District of Ohio for coordinated pretrial proceedings before Judge Edmund A. Sargus Jr. In re: Davol, Inc./C.R. Bard, Inc. Polypropylene Hernia Mesh Products Liability Litigation, MDL No. 2846.
First MDL Bellwether Trial Ends in Defense Verdict
First Bard MDL 2846 bellwether trial concludes with defense verdict for Bard. Trial had been rescheduled multiple times due to COVID-19 pandemic, per amended CMOs 23-A through 23-D.
$4.8M Rhode Island State Court Verdict
Rhode Island state court jury awards $4.8 million in compensatory damages to plaintiff Paul Trevino in Bard hernia mesh trial.
Settlement Master Appointed to MDL
Judge Sargus appoints Settlement Master to facilitate resolution discussions in MDL 2846.
$500K Plaintiff Verdict in Second MDL Trial
Second Bard MDL 2846 bellwether trial results in $500,000 verdict for plaintiff. Antonio Milanesi case.
Fourth Bellwether Trial Vacated; Mediation Ordered
Judge Sargus vacates April 2024 trial date for fourth bellwether case and orders in-person mediations, per CMO issued February 16, 2024.
CMO 52 Imposes Limited Stay Pending Settlement
Judge Sargus enters Case Management Order #52 on July 6, 2024, imposing limited stay on all MDL 2846 cases filed on or before that date. Stay prohibits discovery, motions, and trial settings.
Confidential Settlements in Rhode Island and Ohio
Bard reaches confidential settlements to resolve significant number of lawsuits in Rhode Island state court and Ohio federal court.
Global Settlement of 38,000 Claims Announced
Global settlement reached covering approximately 38,000 Bard hernia mesh claims pending in MDL 2846 and Rhode Island state court. Settlement amount believed to exceed $1 billion.
Statute of limitations
MDL 2846 global settlement announced October 2024; over 20,000 claims resolving. New filings post-July 6, 2024 face heightened pleading requirements per CMO #52: plaintiffs must certify under penalty of perjury within 21 days that claims are not time-barred and produce causation expert reports within 90 days. MDL proceedings do not toll state SOLs. Rhode Island state court remains active forum with favorable Anthony discovery rule jurisprudence; $4.8M verdict in Stinson case (August 2022). Judge Sargus imposed strict docket control measures; settlement payouts expected 2025-2026.
Rhode Island
3 years from discovery
Rule: Discovery rule applies per Anthony v. Abbott Labs, 677 A.2d 1036 (R.I. 1996); cause accrues when plaintiff knew or should have known of injury and its causal connection to the product
Discovery: Liberal discovery rule: statute runs from when victim discovers or reasonably should discover wrongdoing by manufacturer, not merely injury occurrence
RI Superior Court (Providence) maintains personal jurisdiction over C.R. Bard; favorable venue for out-of-state plaintiffs. See Recine v. Davol Inc.
⚠Ohio (MDL 2846)
2 years from discovery
Rule: Ohio Rev. Code § 2305.10(C); discovery rule applies for product liability claims
Discovery: Accrual upon discovery of injury and its causal link to the product
MDL 2846 (In re: Davol/C.R. Bard Hernia Mesh Prods. Liab. Litig.) centralized before Judge Edmund A. Sargus, Jr., S.D. Ohio. Post-July 6, 2024 filings subject to strict CMO #52 'Lone Pine' requirements: 14-day pharmacy/physician list, 21-day SOL certification under penalty of perjury, 90-day causation expert report. See CMO #52 (July 6, 2024)
Florida
4 years from discovery
Rule: Fla. Stat. § 95.11(3)(a), (e); discovery rule codified
Discovery: Accrues upon discovery of injury and reasonable connection to product
12-year statute of repose for products liability per § 95.031(2)(b) may bar older implants
Maine
6 years from discovery
Rule: 14 Me. Rev. Stat. Ann. § 752; longest SOL period for product liability
Discovery: Discovery rule applies; accrues upon discovery of injury and cause
Longest available SOL period; favorable for delayed-manifestation mesh injuries
Missouri
5 years from discovery
Rule: Mo. Rev. Stat. § 516.120; discovery rule applies for product liability
Discovery: Accrues upon discovery of injury and its causal connection to product
No statutory repose for product liability claims
North Dakota
6 years from discovery
Rule: N.D. Cent. Code § 28-01-16; longest SOL period for product liability
Discovery: Discovery rule applies; accrues upon discovery of injury and cause
6-year period matches Maine as longest available; favorable for delayed-manifestation cases
Minnesota
4 years from discovery
Rule: Minn. Stat. § 541.05; discovery rule applies for product liability
Discovery: Accrues upon discovery of injury and its causal connection
No statutory repose for product liability; 4-year period favorable for mesh cases
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| Rhode Island | 3 years from discovery | Discovery rule applies per Anthony v. Abbott Labs, 677 A.2d 1036 (R.I. 1996); cause accrues when plaintiff knew or should have known of injury and its causal connection to the product | Liberal discovery rule: statute runs from when victim discovers or reasonably should discover wrongdoing by manufacturer, not merely injury occurrence | RI Superior Court (Providence) maintains personal jurisdiction over C.R. Bard; favorable venue for out-of-state plaintiffs. See Recine v. Davol Inc. |
| ⚠Ohio (MDL 2846) | 2 years from discovery | Ohio Rev. Code § 2305.10(C); discovery rule applies for product liability claims | Accrual upon discovery of injury and its causal link to the product | MDL 2846 (In re: Davol/C.R. Bard Hernia Mesh Prods. Liab. Litig.) centralized before Judge Edmund A. Sargus, Jr., S.D. Ohio. Post-July 6, 2024 filings subject to strict CMO #52 'Lone Pine' requirements: 14-day pharmacy/physician list, 21-day SOL certification under penalty of perjury, 90-day causation expert report. See CMO #52 (July 6, 2024) |
| Florida | 4 years from discovery | Fla. Stat. § 95.11(3)(a), (e); discovery rule codified | Accrues upon discovery of injury and reasonable connection to product | 12-year statute of repose for products liability per § 95.031(2)(b) may bar older implants |
| Maine | 6 years from discovery | 14 Me. Rev. Stat. Ann. § 752; longest SOL period for product liability | Discovery rule applies; accrues upon discovery of injury and cause | Longest available SOL period; favorable for delayed-manifestation mesh injuries |
| Missouri | 5 years from discovery | Mo. Rev. Stat. § 516.120; discovery rule applies for product liability | Accrues upon discovery of injury and its causal connection to product | No statutory repose for product liability claims |
| North Dakota | 6 years from discovery | N.D. Cent. Code § 28-01-16; longest SOL period for product liability | Discovery rule applies; accrues upon discovery of injury and cause | 6-year period matches Maine as longest available; favorable for delayed-manifestation cases |
| Minnesota | 4 years from discovery | Minn. Stat. § 541.05; discovery rule applies for product liability | Accrues upon discovery of injury and its causal connection | No statutory repose for product liability; 4-year period favorable for mesh cases |
Live intelligence
AI litigation brief
Bard Hernia Mesh remains established mass tort / active mdl with 37 current signals in the accepted feed.
Overview
MDL 2846 is in post-settlement administration following Becton Dickinson's October 2024 global settlement framework. Judge Edmund A. Sargus, Jr. (S.D. Ohio) has shifted focus to clearing the docket through the Intensive Settlement Process overseen by Special Masters. The court entered CMO #52 in July 2024 imposing a limited stay on discovery and motions during settlement negotiations; CMO #53 implemented Lone Pine-style docket control requirements.
Key developments
Trajectory
Bard Hernia Mesh is moving on the court side on MDL 2846 — docket scheduling and case-management orders should lead the next editorial update.
Editorial intelligence
MDL 2846 should stay on the lead docket watch because it is the primary consolidation vehicle for Bard Hernia Mesh.
Generated Apr 28, 2026, 12:00 AM UTC
37 events detected
No recent news signals. Monitoring is active — this section updates automatically.
No recent PubMed signals. Monitoring is active — this section updates automatically.
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against All Defendants ( Filing fee $ 405 paid - receipt number: AOHSDC-11002008) filed by Sabrina Marshall. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet) (Diaz, Silvino) Modified on 4/23/2026 (bew). (Entered: 04/23/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10990492), filed by Wayne Northcutt, Gloria Northcutt. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/15/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10990301), filed by Colleen Smith. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/15/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard Inc, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10989859), filed by James Haggerty, Deborah Haggerty. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/15/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against All Defendants ( Filing fee $ 405 paid - receipt number: AOHSDC-10988930), filed by Donna Dykes. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/14/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard Inc, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10988869), filed by Carol Crist. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/14/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard Inc, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10988809), filed by Ingrid Rodwell. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/14/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard Inc, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10984095), filed by David Beckerink, Kristin Beckerink. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/11/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against C.R. Bard Inc, Davol Inc ( Filing fee $ 405 paid - receipt number: AOHSDC-10984003), filed by Vincent Russo, Natividad Russo. (Attachments: # 1 Civil Cover Sheet) (Preston, A.) (Entered: 04/10/2026)
Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation
PACER docket entry from OHSD: COMPLAINT with JURY DEMAND against All Defendants ( Filing fee $ 405 paid - receipt number: AOHSDC-10977805), filed by Steve Prediletto. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet) (Diaz, Silvino) (Entered: 04/08/2026)
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
96Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Apr 28, 2026, 12:00 AM UTC
Next: 43:25
Source Monitoring
PACER
PACER
Google News
MAUDE
PubMed
Event feed
37
events detected
AI Brief
Bard Hernia Mesh remains established mass tort / active mdl with 37 current signals in the accepted feed.
Overview
MDL 2846 is in post-settlement administration following Becton Dickinson's October 2024 global settlement framework. Judge Edmund A. Sargus, Jr. (S.D. Ohio) has shifted focus to clearing the docket through the Intensive Settlement Process overseen by Special Masters. The court entered CMO #52 in July 2024 imposing a limited stay on discovery and motions during settlement negotiations; CMO #53 implemented Lone Pine-style docket control requirements.
Key developments
PACER court filing on Apr 23: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation. ‖ MAUDE FDA alert on Mar 31: MAUDE Filing 24745156: VENTRALEX ST.
Generated Apr 28, 2026, 12:00 AM UTC
Tracked MDLs
MDL 2846
S.D. Ohio
Bard/Davol polypropylene hernia mesh